|
Biotest AG
01.06.2017 / 12:41
Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer
Biotest AG
Landsteinerstraße 5
63303 Dreieich
Germany
|
2. Reason for notification
|
|
Acquisition/disposal of shares with voting rights
|
|
X
|
Acquisition/disposal of instruments
|
|
|
Change of breakdown of voting rights
|
|
|
Other reason:
|
3. Details of person subject to the notification obligation
|
Name:
|
City and country of registered office:
|
|
Mr
Yuewen
Zheng
|
|
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
5. Date on which threshold was crossed or reached
6. Total positions
|
|
% of voting rights attached to shares
(total of 7.a.)
|
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
|
total of both in %
(7.a. + 7.b.)
|
total number of voting rights of issuer
|
|
Resulting situation
|
0 %
|
10.75 %
|
10.75 %
|
19785726
|
|
Previous notification
|
0 %
|
8.9 %
|
8.9 %
|
/
|
7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)
|
ISIN
|
absolute
|
in %
|
|
|
direct
(Sec. 21 WpHG)
|
indirect
(Sec. 22 WpHG)
|
direct
(Sec. 21 WpHG)
|
indirect
(Sec. 22 WpHG)
|
|
|
|
|
%
|
%
|
|
Total
|
|
%
|
b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG
|
Type of instrument
|
Expiration or maturity date
|
Exercise or conversion period
|
Voting rights absolute
|
Voting rights in %
|
|
Share purchase agreement outside of stock exchange signed by shareholder giving right to purchase
|
|
|
2126111
|
10.75 %
|
|
|
|
Total
|
|
%
|
b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG
|
Type of instrument
|
Expiration or maturity date
|
Exercise or conversion period
|
Cash or physical settlement
|
Voting rights absolute
|
Voting rights in %
|
|
|
|
|
|
|
%
|
|
|
|
|
Total
|
|
%
|
8. Information in relation to the person subject to the notification obligation
|
|
Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
|
|
X
|
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
|
|
Name
|
% of voting rights (if at least held 3% or more)
|
% of voting rights through instruments (if at least held 5% or more)
|
Total of both (if at least held 5% or more)
|
|
Yuwen Zheng
|
%
|
%
|
%
|
|
Creat Group Co., Ltd.
|
%
|
%
|
%
|
|
Creat Tiancheng Investment Holdings Co., Ltd.
|
%
|
%
|
%
|
|
Tiancheng Fortune Management Limited
|
%
|
%
|
%
|
|
Tiancheng International Investment Limited
|
%
|
%
|
%
|
|
Tiancheng (Germany) Pharmaceutical Holdings AG
|
%
|
10.75 %
|
10.75 %
|
9. In case of proxy voting according to Sec. 22 para. 3 WpHG
|
Date of general meeting:
|
|
|
Holding position after general meeting:
|
% (equals voting rights)
|
10. Other explanatory remarks:
01.06.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
|